Wockhardt To Export 100 Million Sputnik Vaccines

News Comes Following Respectable Q3 Results For Indian Pharma Firm

Indian pharmaceutical firm Wockhardt is set to export up to 100 million doses of the Russian COVID-19 vaccine Sputnik V, through a technology transfer agreement with the Gamaleya National Research Institute of Epidemiology and Microbiology.

Wockhardt company logo icon on website under magnifying glass
Wockhardt's UK business grew by 14% during Q3 • Source: Alamy

Indian pharma firm Wockhardt Limited has received permission from India’s Central Drugs Standard Control Organization to export up to 100 million doses of Russian Sputnik V COVID-19 vaccines. This includes up to 80 million doses of Sputnik Light and up to 20 million doses of Sputnik V Component I.

Wockhardt has entered into an agreement with the Russian Direct Investment Fund and Enso Healthcare to manufacture and supply the...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business